SCHEMBL26474261

SCHEMBL26474261

CC(C)n1ccc(-c2ccc(F)c(F)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
PGR P06401 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
GAA P10253 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
NOTUM Q6P988 1/20 0.38
TRPV3 Q8NET8 1/20 0.37
MAOB P27338 1/20 0.37
TGFBR1 P36897 3/20 0.37
MET P08581 1/20 0.37
PDE1A P54750 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE1C Q14123 1/20 0.37
PDE3A Q14432 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26253756 0.87 KCNH2 (0.40) DYRK1ACA1CA2TRPV3TGFBR1
SCHEMBL12777941 0.81 SCN4A (0.51) DYRK1ACA1CA2ALDH1A1TGFBR1
SCHEMBL14277965 0.79 KEAP1 (0.53) CA1CA2ALDH1A1CYP1A2GAA
SCHEMBL16595866 0.77 DYRK1A (0.44) DYRK1ACA1CA2ALDH1A1GAA
SCHEMBL13273051 0.77 DYRK1A (0.44) DYRK1AALDH1A1GAANOTUMTGFBR1
SCHEMBL22349799 0.75 NPC1 (0.43) DYRK1APGRGAANOTUMMAOB
SCHEMBL2609419 0.75 DYRK1A (0.45) DYRK1AALDH1A1CYP1A2GAACYP2C9
SCHEMBL27013330 0.74 DYRK1A (0.39) DYRK1ANOTUMPDE4DJAK2TYK2
SCHEMBL16911874 0.74 ESR2 (0.41) DYRK1APRMT5WDR77AR
SCHEMBL21051521 0.74 DYRK1A (0.44) DYRK1AALDH1A1TGFBR1PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230135152-A1 PIKFYVE KINASE INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-04 US disclosed
US-20230135152-A1 PIKFYVE KINASE INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230135152-A1 PIKFYVE KINASE INHIBITORS PIKFYVE, PIP5K1B, PIP5K1C DYRK1A 673/4885CA1 4827/4885CA2 3772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.